Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
107 Cards in this Set
- Front
- Back
bleeding during reproductive years ~~
|
Complications of pregnancy
Organic lesions: -Endometritis - Leiomyomas -Polyps -Hyperplasia -Carcinoma DUB |
|
penny-nickel-dime -quarter wrt malignant pot. of hyperplasia:
|
1% if simple and w/o atypia
5% if complex w/o atypia (over 10-15 years) 25% if complex and atypia |
|
most important prognostic factor for surface epithelium carcinomas =
|
stage - whether it's confined to the ovary (stage I) or not
- serous and clear cell = poor prognosis epithelial types - endometrioid and mucinous types = good |
|
histo of endometrioma:
|
hemosiderin-laden mP's within the stroma
|
|
Endometriosis can cause obstruction of the:
|
appendix, resulting in acute appendicitis
|
|
cul-de-sac =
|
pouch of Douglas
|
|
adnexal =
|
appendage of an organ
|
|
"immature" teratoma =
|
not a distinct, mature tissue like bone or skin
- embryonal |
|
teratomas are:
|
GERM-cell tumors
|
|
ovarian torsion can occur with:
|
ANY ovarian mass
|
|
Call-Exner bodies (areas of degeneration) ~~
|
coffee beans on histo
~~ sex-cord tumors |
|
sex-cord tumors are:
|
low-grade malignant
|
|
Infertility =
|
>1 yr unprotected intercourse w/o conception
|
|
Fecundability =
|
probability of achieving pregnancy in a single menstrual cycle
-20-25% in young couples Fecundity = probability of achieving a live birth after attempting conception for a single menstrual cycle |
|
fertile window:
|
- sperm can only survive in the female genital tract for about 5-6 days
- eggs, once ovulated have about a 2 day window to be fertilized => there’s only about a 6-7 day window in which conception could even occur that cycle - highest probability of conception ~~ day 14 (ovulation) |
|
the sperm have to be waiting when:
|
the egg is released
|
|
methods of predicting ovulation:
(3) |
1. ovulation prediction kits
2. basal body temp 3. cervical mucus monitoring |
|
ovulation prediction kits measure:
|
LH,
which increases a day or so before ovulation - m. b/w 11 am and 3 pm |
|
what's the deal with m'g basal body temp?
|
basal body temp increases after ovulation starts
- m. every morning before you get out of bed => add to your diary in order to plan for intercourse your next cycle |
|
rationale behind cervical mucus memb:
|
cervical mucus changes as you approach ovulation
- check toilet paper - type 1 is least fertile - type 4 is most (raw egg whites) => intercourse on day with type 4 mucus results in higher rates of conception |
|
fertilization occurs in the:
|
Fallopian tube
|
|
2 m.c. causes of infertility:
|
1. male factor
2. tubal/peritoneal issue |
|
"male factor" =
(3) |
1. ED
2. ejaculatory dysfunction 3. abnl sperm quality or quantity |
|
Oligospermia =
|
low number of sperm
|
|
Azoospermia =
|
no sperm
|
|
Asthenospermia =
|
poor motility of sperm
|
|
Teratospermia =
|
abnl morphology
|
|
causes of abnl sperm:
(3) |
1. Genetic
- Klinefelters - CFTR mut.– CBAVD - Microdeletion of the Y chromosome 2. Hormonal - Hypothlamic/pituitary dysfunction => lack of stimulation of testis => dec. TEST => dec. production of sperm 3. Environmental toxins - Smoking, radiation, heat (via varicocele) |
|
Klinefelters syndrome =
|
extra X chromosome (46,XXY)
|
|
4 features of Klinefelters:
|
1. c.c. of testicular failure
2. tall 3. small firm testes 4. under-virilized (which means that they don’t have as much male pattern hair or male traits) - due to low TEST due to testicular failure |
|
vas deferens connects:
|
testis to penis
|
|
varicocele =
|
abnly enlarged spermatic vein
=> inc. heat of testis |
|
order of evaluating male infertility:
(3) |
1. semen analysis
2. hormone analysis (including thyroid) 3. genetic workup |
|
male hormone therapy wrt infertility is:
|
unreliable
- exogenous TEST actually decreases sperm count |
|
If the issue is one where sperm is made but not present in the ejaculate (such as CBAVD) then they can undergo:
|
testicular biopsy or aspiration to obtain sperm directly from the teste.
|
|
evaluating ovarian factor in infertility:
(4) |
1. HPO axis
- FSH/LH, estradiol - drawn between cycle day 2-4 2. Thyroid - TSH, Free T4 3. Hyperprolactinemia - Prolactin 4. Genetic - Karyotype, FMR1 (fragile X) |
|
Thyroid disorders and hyperprolactinemia are underlying conditions that when treated:
|
frequently result in resumption of ovulation without further intervention.
|
|
med to induce ovulation:
|
Clomiphene
|
|
4 features of Clomiphene:
|
1. SERM - binds ER'
2. acts as agonist OR antagonist - primarily an antagonist in pre-menopausal women - gives the brain a false perception of low EST 3. tissue specific - acts at hypothalamus 4. **req's functional HPO axis** |
|
Clomiphene blocks ER's in hypothalamus; reduced negative feedback from EST leads to:
|
increased GnRH secretion
=> increased FSH/LH from pituitary => ovarian stimulation This stimulation eventually results in an LH surge and ovulation |
|
If the HPO axis is not functioning, then EST is:
|
ALREADY LOW and therefore clomiphene will not work
|
|
aromatase converts:
|
androgens to estrogens
|
|
aromatase inhibitors help infertility b/c:
|
they dec. amount of estrogen that's made
=> stimulates GnRH to release FSH/LH => ovaries => LH surge => ovulation |
|
aromatase inhibitors ALSO require:
|
an intact HPO axis
|
|
2 aromatase inhibitors:
|
1. Letrozole
2. Anastrozole |
|
difference b/w Clomiphene therapy and aromatase inhibitor therapy:
|
in Clomiphene therapy, EST levels are *perceived* as low, while with Letrozole they are ACTUALLY low
|
|
tubal factors wrt infertility:
(2) |
1. Tubal damage
- Chlamydia inf. - c.c. of obstruction - Gonorrhea - Salpingitis isthmica nodosa (SIN) 2. Adhesions => tubal blockage - Endometriosis - ruptured appendicitis |
|
to dx tubal blockage:
(2) |
1. hysterosalpingogram (HSG)
HSG = fluoroscopic procedure that is done by placing a catheter into the uterus through the cervix and injecting dye. X-rays are then taken and the dye shows up white. The dye goes into the uterus and out the tubes. If you see the dye spill out the end of the tube you know the fallopian tubes are patent (which is good) 2. Chromopertubation during laparoscopy - watch dye come out during surgery |
|
tx of tubal factor:
(2) |
1. surgery
2. IVF (much more successful) |
|
uterine factors wrt infertility:
(4) |
1. septate uterus (developmental)
2. fibroids 3. polyp(s) 4. intrauterine adhesions |
|
dx of uterine factor:
(2) |
1. Hysterosalpingogram (HSG)
2. hydrosonogram/saline infusion sonogram - SIS) (water and U/S instead of dye and x-ray) |
|
tx of uterine factor:
|
surgical, often via hysteroscopy
|
|
tx for unexplained infertility =
(2) |
1. more eggs (superovulation or IVF)
AND 2. more sperm (insemination or IVF) |
|
Superovulation =
|
Increased number of oocytes PER CYCLE
|
|
how is superovulation achieved?
(2) |
1. higher doses of Clomiphene and Letrozole
(oral) 2. FSH (if HPO axis not intact and those two drugs^ useless) |
|
risk of superovulation =
|
higher chance of multiples
|
|
IVF is a tx for:
(3) |
1. male,
2. tubal, and 3. unexplained infertility |
|
IVF involves stimulation of the ovaries with:
|
gonadotropins.
- Just like superovulation requires a higher dose than ovulation induction, IVF requires an even higher dose than superovulation |
|
in IVF, we don't want the LH surge/ovulation to happen too early (before the oocytes mature i.e. are able to be fertilized); 2 ways to prevent LH surge/ovulation:
|
1. GnRH antagonist
- administer when the EST approaches a level that might lead to the LH surge 2. non-pulsatile GnRH *agonist* - initially stimulates FSH/LH, then pit. becomes desensitized => FSH/LH desensitized |
|
In order to achieve downregulation at the desired time, (non-pulsatile) GnRH agonists must be administered:
|
PRIOR to starting stimulation with exogenous gonadotropins
|
|
Although we do not want a natural LH surge to occur, mostly because we want to be in control of the timing, we do need to simulate an LH surge so that the oocytes are able to complete maturation and be released from the wall of the follicle so that they are floating freely in the follicular fluid and can be aspirated. Therefore we create a *pharmacologic* LH surge.
|
use hCG (trigger shot)
- longer half-life than LH (24 hours vs. 20 min) => resumption of oocyte maturation. - egg retrieval is usually performed approximately 35 hours after the trigger shot |
|
Intracytoplasmic Sperm Injection IVF =
|
injecting one sperm into each egg
|
|
Ganerelix =
|
GnRH antagonist
|
|
Leuprolide =
|
GnRH *agonist*
|
|
Premature ovarian failure =
|
as cessation of menses due to ovarian failure prior to 40 y.o.
- phenotype and morbidity will vary depending on timing of process and etiology |
|
etiology of premature ovarian failure:
|
largely unknown, but genetic with increased rate of follicle disappearance/atresia
- m.c.ly 45X, 47XXY - more common in families with Fragile X |
|
climacteric = perimenopause =
|
gradual regression of ovarian function
|
|
features of climacteric:
(4) |
1. initially have shortened follicular phase (short cycle)
2. followed by episodic ovulation (lengthening of cycle). 3. metrorrhagia is NEVER nl 4. increasing symptoms |
|
symptoms of perimenopause:
(4) |
1. *vasomotor instability* (85%)
(referring to the constriction/dilation of blood vessles) 2. => sleep disturbances 3. => mood disturbances. 4. Somatic symps (fatigue, palpitations, HA/migraine, breast pain and enlargement) |
|
perimenopause follows:
|
decreasing fertility
|
|
menopause =
|
*permanent* cessation of menstruation caused by failure of ovarian follicular development in the presence of high gonadotrophin levels
~~51-52 - a clinical dx - no menses for 12 months |
|
menopause is genetically determined but definitely influenced by environment;
|
smoking ~~ earlier menopause
|
|
***hormone levels in menopause:***
(4) |
high FSH,
low EST, low inhibin (no follicles) NO Prog (since there's no ovulation) |
|
5 key physical signs of menopause:
|
1. vasomotor instability => hot flashes
2. Metabolic Changes 3. CAD 4. bone loss 5. Urogenital atrophy (includes bladder) |
|
4 post-menopausal health risks:
|
Osteoporosis
CV dz Breast/Endometrial/Ovarian/Colon Cancer Incontinence and pelvic organ prolapse |
|
greatest bone loss occurs:
|
immediate 10 years after menopause
|
|
risk factors for osteoporosis:
|
White or Asian
Smoking Alcohol Caffeine Sedentary Low BMI Chronic steroid use Premature menopause Calcium and Vitamin D deficiency. |
|
consequences of osteoporosis:
(4) |
1. Spinal (vertebral) compression fractures
- Back pain - Loss of height and mobility - Postural deformities 2. Colles’ (forearm) fractures 3. Hip Fractures 4. Tooth loss |
|
EST *cannot* increase bone mass; instead, it:
(1 => 4) |
**reduces bone resorption**
1. blocks action of parathyroid hormone 2. inc.'s calcitonin 3. stimulates osteoblasts 4. inc's Ca2+ absorption |
|
best screening for osteoporosis =
|
DEXA
- evaluate spine and femoral neck - indicated for all women > 65 or, <65 with 1 risk factor for osteoporosis |
|
tx to offset osteoporosis:
(6) |
1. HRT
- start within 5 years of menopause, continue for 10 years 2. Bisphosphonates (-dronates) 3. PTH 4. Denosumba - blocks RANKL 5. Ca2+/Vit. D 6. SERM's (Raloxifene, Tamoxifen) |
|
Raloxifene interactions with EST:
(2) |
1. EST agonist on bone,
2. EST *antagonist* on breast, endometrium, vagina |
|
Tamoxifen interactions with EST:
(2) |
1. EST agonist on bone, endometrium
2. EST antagonist on breast |
|
primary mechanism of Bisphosphonates =
|
inhibition of osteoclast bone resorption
|
|
at >65 y.o., male to female ratio of MI's =
|
1:1
- heart dz kills many more women than BC |
|
4 functions of PROG:
|
1. inhibits LH/FSH
2. thickens cervical mucus 3. thins endometrium 4. decreases tubal motility |
|
reproductive aging ~~
|
hormonal changes
|
|
menopause can be induced by:
|
removing both ovaries
|
|
best therapy for hot flashes:
|
EST
|
|
hot flashes/night sweats =>
|
sleep and mood disturbances
- women w/ hx of depression may => recurrence |
|
urogenitary symps during menopause:
(7) |
1. Dysuria
2. Urgency 3. Frequency 4. Recurrent UTIs 5. Dysparunia 6. Pruritus 7. stenosis of vagina |
|
tx for urogenitary symps:
(2) |
1. vaginal EST
2. HRT |
|
metabolic syndrome of menopause:
(3) |
1. lipid triad
(inc. TG's, Inc. LDL, dec. HDL) 2. insulin R 3. endothelial dysfunction, others |
|
first-line tx's of osteoporosis:
(2) |
1. Bisphosphonates
2. Raloxifene |
|
other reasons why EST must be the solution to menopause:
|
Lowers LDL
Increases HDL Increases triglycerides Increases venous and arterial thromboembolism Improves vascular function Reduces atherosclerosis formation Improves insulin sensitivity (reduction in type 2 DM) |
|
HRT of just EST is ONLY for:
|
women w/o a uterus
- if you have a uterus, need progestin to oppose EST's affect at the uterus |
|
current recommendations for HRT:
|
take the lowest dose and for the shortest amount of time while you're going through menopause
|
|
early menopause =
|
ages 40-44
|
|
premature menopause =
|
<40
- caused by premature ovarian failure OR surgical removal of ovaries |
|
premature ovarian failure =
(4) |
1. sex chromosome abnormalities
(usually involving the X Chromosome) 2. Fragile X premutation 3. AI 4. Chemotherapy/Irradiation |
|
to evaluate premature ovarian failure:
(3) |
1. karyotype (<30 years of age)
2. assessment for Fragile X (number of CGG repeats) 3. Survey for other AI dz's (such as hypothyroidism, adrenal insufficiency) |
|
menopause results from failure of:
|
ovarian follicular development
|
|
what is responsible for the rise of FSH in menopause?
|
low inhibin
|
|
ALL osteoporosis therapies work by:
|
reducing bone resorption
|
|
what's the biggest killer of post-menopausal women?
|
CHD
|
|
in women with a uterus, EST must ALWAYS be:
|
accompanied by PROG
|
|
HRT is associated with increased rates of:
(4) |
CHD, BC, PE, and stroke
|